Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2.
Accurate estimations of the seroprevalence of antibodies to severe acute respiratory syndrome coronavirus 2 need to properly consider the specificity and sensitivity of the antibody tests. In addition, prior knowledge of the extent of viral infection in a population may also be important for adjusting the estimation of seroprevalence. For this purpose, we have developed a Bayesian approach that can incorporate the variabilities of specificity and sensitivity of the antibody [...]
Author(s): Dong, Qunfeng, Gao, Xiang
DOI: 10.1093/jamiaopen/ooaa049